Name | NEFROLAYN-SK, OOO |
|---|
INN | 2014013500 |
|---|
KPP | 201401001 |
|---|
OGRN | 1162036055323 |
|---|
OKPO | 03569217 |
|---|
Address | 364016, Chechenskaya Respublika, g Groznyy, ul 8 Marta (baysangurovskiy R-n), d. D. 2/9, of. KABINET 1 |
|---|
Phone | +7 (995) 953-80-39, (912) 257-88-99 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 86.10 | Core activity | Hospitals | | 86.21 | Additional activity | General practice | | 86.90.9 | Additional activity | Other independent activities in health care |
Registration date | 24.06.2016 |
|---|
|
NEFROLAYN-SK, OOO (Chechen Republic; INN 2014013500) was registered on 24 Jun 2016. The company's authorized capital as of July 1, 2012 was 100000 rub. Principal activities of NEFROLAYN-SK, OOO: hospitals (86.10), general practice (86.21), other independent activities in health care (86.90.9). |
Economic indicators2024
Net loss (RAS) of NEFROLAYN-SK, OOO increased 3.75 times to 47.72 million RUB from 12.71 million RUB over 2023, the company informed. Revenue increased in the accounting period by 0.88% to 262.07 million RUB from 259.78 million RUB over 2023; cost of goods sold grew by 14.23% to 306.53 million RUB from 268.33 million RUB; sales loss grew 5.13 times to 44.46 million RUB from 8.67 million RUB. 2023
Net loss (RAS) of NEFROLAYN-SK, OOO increased 17.46 times to 12.74 million RUB from 730.00 thousand RUB over 2022, the company informed. Revenue increased in the accounting period by 38.64% to 259.78 million RUB from 187.39 million RUB over 2022; cost of goods sold grew by 43.85% to 268.33 million RUB from 186.53 million RUB; sales loss made up 8.66 million RUB compared to sales profit of 854.00 thousand RUB. 2022
Net loss (RA) of NEFROLAYN-SK, OOO made up 730.00 thousand RUB over 2022 compared to net profit of 3.53 million RUB over 2021, the company informed. Revenue increased in the accounting period by 43.34% to 187.39 million RUB from 130.73 million RUB over 2021; cost of goods sold grew 1.51 times to 186.53 million RUB from 123.87 million RUB; sales profit fell 7.88 times to 854.00 thousand RUB from 6.73 million RUB. 2021
Net profit (RAS) of NEFROLAYN-SK, OOO grew over 2021 by 31.63% to 3.53 million RUB from 2.68 million RUB over 2020, the company informed. Revenue increased in the accounting period 1.61 times to 130.73 million RUB from 81.14 million RUB over 2020; cost of goods sold grew 1.61 times to 123.87 million RUB from 76.74 million RUB; sales profit went up 1.53 times to 6.73 million RUB from 4.39 million RUB. 2020
Net profit (RAS) of NEFROLAYN-SK, OOO made up 2.68 million RUB over 2020 compared to net loss of 7.04 million RUB over 2019, the company informed. Revenue increased in the accounting period 1.60 times to 81.14 million RUB from 50.67 million RUB over 2019; cost of goods sold grew by 35.12% to 76.74 million RUB from 56.80 million RUB; sales profit made up 4.39 million RUB compared to sales loss of 6.13 million RUB. 2019
Net loss (RAS) of NEFROLAYN-SK, OOO dropped over 2019 by 27.80% to 7.04 million RUB from 9.75 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period by 30.16% to 50.67 million RUB from 38.93 million RUB over 2018; cost of goods sold grew by 17.99% to 56.80 million RUB from 48.13 million RUB; sales loss decreased by 33.44% to 6.13 million RUB from 9.20 million RUB. 2018
Net loss (RAS) of NEFROLAYN-SK, OOO increased 6.35 times to 9.75 million RUB from 1.54 million RUB over 2017, the company informed. Cost of goods sold grew 32.90 times to 48.13 million RUB from 1.46 million RUB; sales loss grew 6.29 times to 9.20 million RUB from 1.46 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|